key: cord-0981888-2q0rxmrs
authors: Lai, Chih-Cheng; Chen, Shey-Ying; Yen, Muh-Yong; Lee, Ping-Ing; Ko, Wen-Chien; Hsueh, Po-Ren
title: The impact of the coronavirus disease 2019 epidemic on notifiable infectious diseases in taiwan: A database analysis
date: 2021-02-25
journal: Travel Med Infect Dis
DOI: 10.1016/j.tmaid.2021.101997
sha: f01ffebeb2f93402b97d82113eb9b356d1c88e24
doc_id: 981888
cord_uid: 2q0rxmrs

INTRODUCTION: The impact of the COVID-19 pandemic on the incidence of notifiable infectious diseases (NIDs) in Taiwan remains unclear. MATERIALS AND METHODS: The number of cases of NID (n = 42) between January and September 2019 and 2020 were obtained from the open database from Taiwan Centers for Disease Control. RESULTS: The number of NID cases was 21,895 between January and September 2020, which was lower than the number of cases during the same period in 2019 (n = 24,469), with a decline in incidence from 102.9 to 91.7 per 100,000 people in 2019 and 2020, respectively. Fourteen airborne/droplet, 11 fecal-oral, seven vector-borne, and four direct-contact transmitted NID had an overall reduction of 2700 (−28.1%), 156 (−23.0%), 557 (−54.8%), and 73 (−45.9%) cases, respectively, from 2019 to 2020. Similar trends were observed for the changes in incidence, which were 11.5 (−28.4%), 6.7 (−23.4%), 2.4 (−55.0%), and 0.3 (−46.2%) per 100,000 people for airborne/droplet, fecal-oral, vector-borne, and direct-contact transmitted NID, respectively. In addition, all the 38 imported NID showed a reduction of 632 (−73.5%) cases from 2019 to 2020. In contrast, 4 sexually transmitted diseases (STDs) showed an increase of 903 (+7.2%) cases from 2019 to 2020, which was attributed to the increase in gonorrhea (from 3220 to 5028). The overall incidence of STDs increased from 52.5 to 56.0 per 100,000 people, with a percentage change of +6.7%. CONCLUSION: This study demonstrated a collateral benefit of COVID-19 prevention measures for various infectious diseases, except STDs, in Taiwan, during the COVID-19 epidemic.

with reduced access to guidelines and recommended care, and increased in-hospital 68 mortality, evaluated using a national cohort of hospitalized acute myocardial 69 infarction patients [4] . Regarding stroke, access to acute stroke diagnostics and 70 time-dependent therapies was limited or delayed owing to reduced emergency service 71 capacities, and a marked reduction in the number of patients admitted with transient 72 ischemic attack and/or stroke was noted in the emergency departments of three with a high burden of COVID-19. We speculated whether a similar scenario would be 96 demonstrated in a country with a well-controlled COVID-19 outbreak, such as in 97

Taiwan. 98 J o u r n a l P r e -p r o o f

As of October 28, 2020, there have been 550 confirmed cases of COVID-19 in 101

Taiwan, based on the surveillance of 101,021 suspected cases and 220,971 tests [22] . 102

The overall prevalence of COVID-19 in Taiwan was 2.31 per 100,000 people. Among 103 them, more than 80% of the cases were classified as imported, and only 55 cases were 104 classified as locally transmitted. Moreover, with only 7 deaths reported, the overall 105 case fatality rate was 1.3% [22] . All these findings indicate that the control of 106 cases in Taiwan from January 1 to September 31, 2020 and implementation of 119 infection-control measures are illustrated in Fig. 1 

The mean and standard deviation of the number of cases were reported as continuous 150 variables, and differences in the numbers were evaluated using the Student's t-test. 151

Overall, 42 NID were included in this study. The number of cases was 21,895 in 155 2020 (January-September), which was lower than the number of cases recorded in 156 2019 (n = 24,469). Thus, the percent change in the total number of cases between 157 2020 and 2019 was -10.5% (n = 2,574). In addition, the incidence of these 42 diseases 158 was 91.7 and 102.9 per 100,000 people in 2020 and 2019, respectively, with a -10.9% 159 change. Among these diseases, 30 NID had fewer cases in 2020 than in 2019. In 

In this study, the number of severe influenza cases was 433 in 2020, which was 207 much lower than that in 2019 (n = 1,800). In January, the monthly number was 375 in 208 2020, which was higher than those in January 2019 (254). However, the monthly 209 number of cases of severe influenza in the other months of 2020 was significantly 210 lower than those in the same period in 2019 (p = 0.033) (Fig. 3A ). In the 2017-18 211 season, the influenza vaccine coverage for elderly ≥65 years-old, school-aged 212 children/adolescent 7-18 years-old and children 0.5-6 years-old were 45%, 70% and 213 69%, respectively. In the 2018-19 season, the influenza vaccine coverage for elderly 214 ≥65 years-old, school-aged children/adolescent 7-18 years-old and children 0.5-6 215 years-old were 51%, 77% and 80%, respectively. Overall, the coverage rate of 216 influenza vaccine in Taiwan was 47% during the 2018-2019 season, which was 5 % 217 higher than those in the 2017-2018 season (42%). As for gonorrhea, the monthly 218 number of cases in 2020 was significantly higher than that in 2019 (p = 0.0001) ( Although the findings of this study were significant, there was several limitations. 

Contact tracing 414 assessment of COVID-19 transmission dynamics in Taiwan and risk at different 415 exposure periods before and after symptom onset

Masks and medical 418 care: Two keys to Taiwan's success in preventing COVID-19 spread

public health response to COVID-19 in Singapore

The impact of

COVID-19 preventative measures on airborne/droplet-transmitted infectious 435 diseases in Taiwan

Rapid decline of 438 seasonal influenza during the outbreak of COVID-19

Ministry of Health LaW, Diseases NIoI

COVID-19 pandemic on Measles surveillance in Pakistan

Is 452 COVID-19 affecting the epidemiology of STIs? The experience of syphilis in

The impact of COVID-19 on the diagnosis of TB 456 in Taiwan

Increase in sexually transmitted infection 458 during the COVID-19 pandemic in Taiwan

Invasive pneumococcal diseases (320/178)

Varicella (50/39) 8. Mumps (451/379)

Legionella infection (207/212)

Invasive Haemophilus influenzae type b infection (1/3)

Acute flaccid paralysis and poliomyelitis (50/21)

Amoebiasis (258/184)

Listeriosis (145/111)

Acute hepatitis A virus infection (73/65)